{
    "organizations": [],
    "uuid": "eb70f433003060948d76bc221ce1118d26e91c9a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/buzz-eiger-biopharma-abandons-blood-pres/buzz-eiger-biopharma-abandons-blood-pressure-drug-after-trial-failure-idUSL3N1PB468",
    "ord_in_thread": 0,
    "title": "BUZZ-Eiger BioPharma: Abandons blood pressure drug after trial failure",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "** Drug developer’s shares fall 44.4 pct at $8.90 premarket\n** Top pct loser among all U.S.-listed stocks premarket\n** Says it would stop developing its drug to treat pulmonary arterial hypertension (PAH), a type of high blood pressure, after it failed a mid-stage study\n** The drug did not show improvement in PAH - the study’s main goal\n** PAH occurs when the arteries of the lungs constrict, forcing the heart to work harder and potentially leading to its failure\n** However, the company says it would continue testing the drug, ubenimex, for lymphedema, a blockage of fluid causing swelling in the arms and legs\n** Up to Friday’s close, stock had risen 36.17 pct in the past twelve months (Reporting by Akankshita Mukhopadhyay in Bengaluru)\n ",
    "published": "2018-01-16T21:42:00.000+02:00",
    "crawled": "2018-01-17T19:58:12.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "drug",
        "developer",
        "share",
        "fall",
        "pct",
        "premarket",
        "top",
        "pct",
        "loser",
        "among",
        "stock",
        "premarket",
        "say",
        "would",
        "stop",
        "developing",
        "drug",
        "treat",
        "pulmonary",
        "arterial",
        "hypertension",
        "pah",
        "type",
        "high",
        "blood",
        "pressure",
        "failed",
        "study",
        "drug",
        "show",
        "improvement",
        "pah",
        "study",
        "main",
        "goal",
        "pah",
        "occurs",
        "artery",
        "lung",
        "constrict",
        "forcing",
        "heart",
        "work",
        "harder",
        "potentially",
        "leading",
        "failure",
        "however",
        "company",
        "say",
        "would",
        "continue",
        "testing",
        "drug",
        "ubenimex",
        "lymphedema",
        "blockage",
        "fluid",
        "causing",
        "swelling",
        "arm",
        "leg",
        "friday",
        "close",
        "stock",
        "risen",
        "pct",
        "past",
        "twelve",
        "month",
        "reporting",
        "akankshita",
        "mukhopadhyay",
        "bengaluru"
    ]
}